Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina MacMillan

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|May 23, 2007
Fine-needle aspiration biopsy of the thyroid: atypical cytopathological featuresMoshe Yehuda, Richard J Payne, Raewyn M Seaberg, et al.
Plos One|February 20, 2015
Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomasJasmeet Assi, Gunjan Srivastava, Ajay Matta, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Decision making for the extent of thyroidectomy in the patient with atypical cytologic resultsManish D Shah, Andrew Conrad, Aadil Ahmed, et al.
BMC Cancer|June 29, 2010
EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosisRanju Ralhan, Jun Cao, Terence Lim, et al.
Head & Neck|December 13, 2023
SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two casesJessie Fuoco, Michelle Huang, Najmeh Esfandiari, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 21, 2005
Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancerNathalie Audet, Nigel J Beasley, Christina MacMillan, et al.
Oncotarget|April 19, 2016
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variantsSubrata Chowdhury, Joe Veyhl, Fatima Jessa, et al.
BMC Cancer|July 17, 2016
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosisRaj Thani Somasundaram, Jatinder Kaur, Iona Leong, et al.
Head and Neck Pathology|September 28, 2022
A 10-Year Review of Intraoral Salivary Gland Tumor Diagnoses: Diagnostic Challenges and Inter-Observer AgreementJessie Fuoco, Mei Dong, Christina MacMillan, et al.
Plos One|August 23, 2012
Biotinidase is a novel marker for papillary thyroid cancer aggressivenessAnthony K-C So, Jatinder Kaur, Ipshita Kak, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Archives of Otolaryngology--Head & Neck Surgery|May 23, 2007
Fine-needle aspiration biopsy of the thyroid: atypical cytopathological featuresMoshe Yehuda, Richard J Payne, Raewyn M Seaberg, et al.
Plos One|February 20, 2015
Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomasJasmeet Assi, Gunjan Srivastava, Ajay Matta, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Decision making for the extent of thyroidectomy in the patient with atypical cytologic resultsManish D Shah, Andrew Conrad, Aadil Ahmed, et al.
BMC Cancer|June 29, 2010
EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosisRanju Ralhan, Jun Cao, Terence Lim, et al.
Head & Neck|December 13, 2023
SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two casesJessie Fuoco, Michelle Huang, Najmeh Esfandiari, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 21, 2005
Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancerNathalie Audet, Nigel J Beasley, Christina MacMillan, et al.
Oncotarget|April 19, 2016
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variantsSubrata Chowdhury, Joe Veyhl, Fatima Jessa, et al.
BMC Cancer|July 17, 2016
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosisRaj Thani Somasundaram, Jatinder Kaur, Iona Leong, et al.
Head and Neck Pathology|September 28, 2022
A 10-Year Review of Intraoral Salivary Gland Tumor Diagnoses: Diagnostic Challenges and Inter-Observer AgreementJessie Fuoco, Mei Dong, Christina MacMillan, et al.
Plos One|August 23, 2012
Biotinidase is a novel marker for papillary thyroid cancer aggressivenessAnthony K-C So, Jatinder Kaur, Ipshita Kak, et al.
Pageof 4